Advances in Research of Hydrogel Microneedle-Based Delivery Systems for Disease Treatment DOI Creative Commons
Juan Cao, Bo Wu, Ping Yuan

et al.

Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(12), P. 1571 - 1571

Published: Dec. 9, 2024

Microneedles (MNs), composed of multiple micron-scale needle-like structures attached to a base, offer minimally invasive approach for transdermal drug delivery by penetrating the stratum corneum and delivering therapeutic agents directly epidermis or dermis. Hydrogel microneedles (HMNs) stand out among various MN types due their excellent biocompatibility, high drug-loading capacity, tunable drug-release properties. This review systematically examines matrix materials fabrication methods HMN systems, highlighting advancements in natural synthetic polymers, explores applications treating conditions such as wound healing, hair loss, cardiovascular diseases, cancer. Furthermore, potential HMNs disease diagnostics is discussed. The identifies key challenges, including limited mechanical strength, efficiency, lack standardization, while proposing strategies overcome these issues. With integration intelligent design enhanced control over dosage safety, are poised revolutionize expand personalized medicine.

Language: Английский

Iontophoresis-driven transdermal drug delivery system based on porous microneedles for hyperuricemia treatment DOI
Rui Wang, Han Wang, Rui Yao

et al.

International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125290 - 125290

Published: Jan. 1, 2025

Language: Английский

Citations

0

Polymeric microneedle advancements in macromolecule drug delivery: current trends, challenges, and future perspectives DOI

Madhuchandra Kenchegowda,

Mohit Angolkar, Umme Hani

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: April 17, 2025

Language: Английский

Citations

0

Leech bionic Hirudin fusion protein prodrug loaded microneedles for long-term inhibition of thrombosis DOI

Xue Tian,

Shuo Su,

Yuhan Wu

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: unknown, P. 113759 - 113759

Published: April 1, 2025

Language: Английский

Citations

0

Microneedle drug delivery carriers capable of achieving sustained and controlled release function DOI

Guangxi Zhai,

Jiayi Shao,

Yunshu Xu

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: 253, P. 114767 - 114767

Published: May 6, 2025

Language: Английский

Citations

0

Porous Microneedles: Transdermal Salt Bridge for Biomedical Device Engineering DOI Creative Commons
Gaobo Wang, Yuina Abe, Soichiro Tottori

et al.

Current Opinion in Biomedical Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 100593 - 100593

Published: May 1, 2025

Language: Английский

Citations

0

Toward precision medicine: End-to-end design and construction of integrated microneedle-based theranostic systems DOI
Yiming Qin, Feiyun Cui, Yifei Lü

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 377, P. 354 - 375

Published: Nov. 23, 2024

Language: Английский

Citations

1

Advances in Research of Hydrogel Microneedle-Based Delivery Systems for Disease Treatment DOI Creative Commons
Juan Cao, Bo Wu, Ping Yuan

et al.

Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(12), P. 1571 - 1571

Published: Dec. 9, 2024

Microneedles (MNs), composed of multiple micron-scale needle-like structures attached to a base, offer minimally invasive approach for transdermal drug delivery by penetrating the stratum corneum and delivering therapeutic agents directly epidermis or dermis. Hydrogel microneedles (HMNs) stand out among various MN types due their excellent biocompatibility, high drug-loading capacity, tunable drug-release properties. This review systematically examines matrix materials fabrication methods HMN systems, highlighting advancements in natural synthetic polymers, explores applications treating conditions such as wound healing, hair loss, cardiovascular diseases, cancer. Furthermore, potential HMNs disease diagnostics is discussed. The identifies key challenges, including limited mechanical strength, efficiency, lack standardization, while proposing strategies overcome these issues. With integration intelligent design enhanced control over dosage safety, are poised revolutionize expand personalized medicine.

Language: Английский

Citations

0